Filing metadata

Accession number
0001062993-22-010574
Form type
Form 4
Filer
Inozyme Pharma, Inc.
CIK
CIK 1693011
Filed
Apr 20, 2022
Reporting period
Apr 19, 2022
Description
Insider transaction

Explore SEC Filings Hub